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Plasma levels of DDE/DDT and liver function in malaria 
control personnel 6 months after indoor residual spraying 
with DDT in northern Uganda, 2008
G S Bimenya, M Harabulema, J P Okot, Olwa Francis, Myers Lugemwa, A L Okwi
Twenty million Ugandans are debilitated each year by malaria. 
Based on available evidence, and in the absence of a better 
and affordable alternative, DDT will continue to be used for 
disease vector control, as recommended by the World Health 
Organization (WHO), while further research clarifies the health 
impact of its use by indoor residual spraying (IRS).1
Government policy therefore requires that DDT use should 
include assessment of its accumulation in the environment and 
an evaluation of its deleterious effects on man and the food 
chain. Consequently, it is necessary to record the applicators’ 
general state of health and the amounts of insecticide 
accumulated during and after IRS, to provide occupational-
hazard values for corrective mitigation and for referral in 
subsequent studies. These data enhance national active 
information collection and reporting on the use of DDT for 
disease vector control.2
Although animal models report dichlorodiphenyl- 
dichloroethylene (DDE)/dichlorodiphenyltrichloroethane 
(DDT) as a possible carcinogen, no such effects have been 
reported in humans.3 However, controversy exists concerning 
the liver: whereas some studies have reported impaired 
liver function,4 others reported an increase in the activity of 
liver enzymes,5  which could indicate liver disease such as 
hepatoma, or the usual enzyme catabolic induction typical of 
aromatic compounds, with no liver disease.6
Our objectives were to determine the concentration of DDE/
DDT in plasma samples from the spray team 6 months after 
their last spraying activity in northern Uganda in 2008, and 
to analyse plasma levels of biochemical markers of disease 
in blood from the spray team after exposure to DDT, so as to 
document acute/mid-term toxicity to internal organs, and 
especially liver function.
Methods
Approval for the study was granted by the Makerere 
University Faculty of Medicine Ethical and Research 
Committee. The project areas included Apac and Oyam 
districts and Lango sub-region (referred to as northern 
Uganda). Six months after the one IRS round of DDT in 
northern Uganda, the Ministry of Health’s Malaria Control 
Programme clinician reviewed and physically examined the 
DDT spray team after obtaining informed and signed consent. 
Venous blood samples (of 5 ml) were collected into heparin 
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Objective. We investigated the relationship between plasma 
levels of dichlorodiphenyltrichloroethane (DDT) and liver 
function in malaria control personnel 6 months after one 
round of DDT indoor residual spraying (IRS).
Method. This was a cross-sectional study in the districts of 
Apac and Oyam of Lango, northern Uganda. Volunteers 
were clinically examined, and 5 ml samples of venous blood 
were taken in heparinised tubes for a 6-month post-spray 
screening for DDT and plasma markers of liver function and 
internal organ disease. DDE/DDT was assayed using ELISA 
kits (Abraxis, USA); plasma enzyme activity concentrations 
of amylase, aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and gamma glutamyl transpeptidase 
(GGT) were analysed using routine clinical chemistry-
automated methods (Konelab, Vantaa, Finland).
Results. All 96 plasma samples analysed for xenobiotics 
contained DDE/DDT in the empirical range of 24.00 - 128.00 
parts per billion (ppb) with a mean (SD) of 77.00 (±26.00) ppb. 
All 119 plasma samples studied for the markers exhibited 
enzyme activity concentration values within the population 
reference ranges, with empirical means (SD) of amylase 71.86 
(34.07), AST 23.83 (12.71), ALT 7.84 (10.01) and GGT 58.37 
(62.68) µg/l.
Conclusion. Six months after IRS with DDT, the spray team 
had an average concentration of plasma DDE/DDT of 77 
ppb. This had no deleterious effect on liver function. We 
recommend continued use of DDT for IRS disease control in 
Uganda until better practical alternatives are available.
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Vacutainer tubes and delivered in cool boxes to the Department 
of Pathology, College of Health Sciences, Makerere University, 
for analysis for DDT and biochemical screening disease 
markers.
Laboratory procedures
The DDT in plasma was extracted with methanol and analysed 
using enzyme-linked immunosorbent assay (ELISA) kits. 
The samples were processed according to the manufacturer’s 
standard operating procedures and quality assurance 
instructions; during the reactions, colour that was inversely 
proportional to the concentration of DDE (the principal 
derivative of DDT) in the sample, developed; its intensity was 
translated and converted into concentration by comparison 
with that produced by the standards and controls supplied 
with the DDT reagent kits. The concentrations were read at 
450 and 630 nm and printed automatically by the ELISA plate 
reader, the Stat FaxReg303 Plus.
Automated routine clinical chemistry methods were used 
in assaying for biochemical disease markers. Heparinised 
plasma samples were analysed for the concentration values 
of amylase, gamma glutamyl transpeptidase (GGT), and the 
transaminases (aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT)) as biochemical screening markers for 
diseases of the internal organs, and specifically the liver.
Results
No abnormalities were detected on clinico-physical 
examination. No plasma abnormalities such as haemolysis, 
turbidity, chylosis, xanthochromia or jaundice were seen 
on visual inspection. The quantitative analytical results are 
presented at two levels: the primary level displays the main 
toxicological measure of interest (the DDT/DDE concentration 
in plasma samples from spray applicators 6 months after the 
one IRS round of DDT), and the secondary level displays the 
concentration values of the selected biochemical markers of 
disease.
DDE/DDT concentration in post-spray plasma
A total of 96 post-spray plasma samples were analysed for 
DDE/DDT concentration 6 months after the one round of DDT 
spraying (distribution shown in Fig. 1).
The DDE/DDT concentration in the post-spray plasma 
ranged empirically from 24 to 128, with a mean (SD) of 77 (26) 
ppb; the spread was near normal but leptokurtic and positively 
skewed; as was expected, there was DDE/DDT in every post-
spray plasma sample analysed. The geometric mean was 71.81 
ppb.
Biochemical markers of diseases of the liver and internal 
organs
A total of 119 plasma samples were analysed for the enzymes 
alpha-amylase, AST, ALT and GGT 6 months after spraying to 
screen for acute/mid-term toxicity of DDE/DDT in the internal 
organs – the liver, pancreas, heart and biliary tract.
Alpha-amylase concentration in post-spray plasma
In 119 post-spray plasma samples analysed for alpha-amylase, 
the mean (SD) enzyme activity concentration was found to be 
71.86 (34.07) with a range of 16.80 - 199.50 µg/l, as shown in 
Fig. 2.
The distribution was polymodal and within the reference 
range of up to 300 µg/l. There was no alert value for any 
internal organ disease, especially not for acute pancreatitis as 
detected by plasma a-amylase in the post-spray plasma.
AST concentration in post-spray plasma
For post-spray AST activity concentration, 119 plasma samples 
were analysed; the mean (SD) was 25.83 (12.71); range 1.00 -  
63.90 µg/l. The distribution was expectedly leptokurtic and 
positively skewed (Fig. 3).
The distribution of 88% of the results was within the 
reference range of up to 40 µg/l; 12% were above the normal 
upper limit of 40 µg/l but within the inducible range of up to 
Fig. 1. DDT concentration in post-spray plasma
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Fig. 1.  DDDT concentration in post-spray plasma.
Fig. 2. Alpha-amylase enzyme activity concentration in post-spray plasma
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Fig. 2.  Alpha-amylase enzyme activity concentration in post-spray 
plasma.
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5 times the upper reference limit; there was no alert value for 
any internal organ disease, and specifically no hepatocellular 
or muscle damage, detected by high AST levels in the post-
spray samples.
ALT enzyme activity concentration in post-spray plasma
In screening for acute/mid-term DDT toxicity in internal 
organs such as the liver, 119 plasma samples were analysed for 
ALT, which resulted in a mean (SD) of 7.80 (5.01) and a range 
of 1.00 - 17.00 µg/l. As expected, the spread was leptokurtic 
and positively skewed (Fig. 4).
The distribution was entirely within the reference range 
of up to 40 µg/l, with no internal organ disease indicated or 
hepatocellular damage detected by high levels of ALT in the 
post-spray samples.
GGT enzyme activity concentration in post-spray plasma
For screening for internal organ disease, for liver disease in 
general and for biliary obstruction in particular, 119 plasma 
samples were analysed for GGT enzyme activity concentration. 
The mean (SD) values were 58.37 (62.68) and from the range 
12.50 - 333.40 µg/l. The spread was expectedly leptokurtic and 
positively skewed (Fig. 5).
Of the results, 75% were within the reference range of <60 
µg/l; 30 were within the drug-inducible range of below 5 times 
the upper limit of the reference range; and there was no liver 
disease or biliary tree abnormality overtly detected by high 
GGT levels in the post-spray plasma samples.
Discussion
Our study found that DDT successfully protected against 
mosquito bites, with no health complaints emerging from 
the clinical history evaluation. We documented a DDE/DDT 
plasma arithmetical mean of 77 ppb, with no biochemically 
alarming concomitant mean values (such as alpha amylase 
– 66.94, AST – 18.18, ALT – 9.33, and GGT – 31.05 µg/l), 
indicating no disease associated with absorbed pesticide 
subsequent to IRS operations. These results refute the 
association of DDT with acute or mid-term diseases of human 
internal organs, especially of the liver; they confirm the safety 
of DDT as used in IRS operations, and strongly commend the 
use of DDT for disease control according to WHO guidelines, 
especially where there are no better and readily available 
alternatives.
The ELISA technology used in this study was highly 
recommended for pesticide analyses, especially in developing 
countries, where it offers the advantages of cost-effectiveness, 
simplicity and speed over chromatographic methods.7 
According to the Abraxis test kit manufacturers, the DDE/DDT 
assay kit used in this study in particular had cross-reactivity to 
organochlorine compounds at different percentages as follows: 
pp`DDE – 100, pp`DDD – 46, op`DDD – 16, pp`DDT – 10, and 
op`DDE – 3.2. Whereas the method largely measured DDE 
(a metabolite of DDT), it did not appreciably measure DDT, 
and blood levels of DDE were, as usual, largely a measure of 
biotransformed DDT dependent inter alia on liver function and 
population genetics. We report and discuss them as DDE/DDT 
complex.
Fig. 5. GGT enzyme activity concentration in post-spray plasma.Fig. 5. GGT enzyme activity concentration in post-spray plasma.
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Fig. 4.  ALT enzyme activity concentration in post-spray plasma.
Fig. 4. ALT enzyme activity concentration in post-spray plasma.
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Fig. 3. AST enzyme activity concentration in post-spray plasma.
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Fig. 3.  AST enzyme activity concentration in post-spray plasma.
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Direct comparison of DDE/DDT versus organ function 
results with previous investigations is hampered by differences 
in study design, analytical facilities and age/population-related 
phenomena, especially among the young.8 Nevertheless, other 
studies had similar findings to ours. In 23 spray workers with 
5.0 (6.3) years’ continuous experience with DDT in Natal,9 
where the sprayers were not required to wear protective 
aspirators, the mean DDE concentration was 129.0 (29.0) 
µg/l (measured by more expensive and time-consuming gas 
chromatography with electron detector) – almost twice as 
high as our finding of 77 ppb. Similarly, in non-sprayers in 
KwaZulu-Natal, 29 adult residents of DDT-sprayed houses had 
an average accumulated plasma DDE concentration increase 
of 34.10 µg/l after 5 months’ initial spraying.8 Again, this is 
close to our mean increase of 14.23 ppb from the pre-spray 
background mean value of 62.92 obtained on recruitment10 of 
sprayers to the post-spray mean value of 77.15 ppb obtained 
6 months after the last DDT spraying activity. A study of 
occupational workers11 showed an increase of total DDT from 
a background mean value of 24 µg/l to a post-spray mean 
value of 130 µg/l over 5 months.11 Our mean concentration 
of DDE/DDT increased from the background mean (SD) of 
63.00(19.00) to the post-spray value of 77.00 (26.00) ppb in the 
period March - October 2008.10 Compared with the results 
obtained in sprayers not protected with aspirators in Natal,9 
we found little increase in DDE/DDT plasma concentration 
among the spray team. This finding is attributed inter alia to 
strict adherence to WHO recommendations for IRS12 of DDT. 
The comparatively little DDE/DDT detected in plasma in 
our study is a testimony that the spray team observed the 
documented safety precautions.13 This contradicts allegations 
of non-adherence to WHO spray guidelines, as lodged in court 
by DDT antagonists,14 and reflects the Uganda Malaria Control 
Programme preparedness in managing IRS.
In DDT applicators in South Africa, Bouwman et al. found 
that serum albumin, alkaline phosphatase, AST and GGT 
concentrations did not differ significantly from those of an 
age-matched control group, although the mean GGT value 
for the applicators was higher than the maximum of the 
laboratory normal range.9 Our ALT values fell entirely within 
the laboratory reference range of <40 µg/l. As ALT is a clinical 
indicator of hepatocellular damage, ostensibly normal values 
obtained in this work coupled with the good clinical history 
and uneventful clinical examination ruled out toxicological 
liver damage within the 6 months after DDT spraying.
Bouwman et al.9 again found values of ALT and GGT in 
the study group higher than in the control and the laboratory 
upper reference limit, respectively. Although expressing 
uncertainities, they still thought that the results suggested the 
possibility of risk to the health of the sprayers.
In our study, with the empirical range of AST being 0.70 - 
 69.90 µg/l, 12% of the plasma samples had values above the 
upper reference limit of 40 µg/l. Similarly, with the empirical 
range of GGT being 12.50 - 333.40 µg/l, 25% of the samples had 
GGT above the population reference limit of 60 µg/l but within 
the aromatic drug/alcohol inducible range for the enzyme.
We caution that laboratory results should not be considered 
in isolation: clinical history and physical examination  should 
ideally precede laboratory investigations. Our mild increases in 
enzyme activities may be explained as follows: besides enzyme 
induction caused by DDT as a xenobiotic, the AST mild 
increase was attributed to the muscular exercise involved in the 
spraying activity; that of amylase was the result of the starch-
rich millet-cassava diet made more prevalent by spray wages, 
and the GGT was because of increased consumption of lira-lira, 
a potent gin which is very popular in Northern Uganda.
This study in Northern Uganda in 2008, 6 months after only 
one round of DDT spraying, should for the first time provide 
the WHO with the essential information previously deemed 
missing, to evaluate exposure/response relationships to 
produce credible risk assessments of DDT use in IRS malaria 
control programmes.
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